These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16845944)

  • 1. [Correlations of pharmacokinetics and pharmacodynamics of a combined preparation containing pyrrolidone and pyroglutamic acid].
    Sariev AK; Lun'shina EV; Zherdev VP; Mirzoian NR
    Eksp Klin Farmakol; 2006; 69(2):58-61. PubMed ID: 16845944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of a drug composition containing pyroglutamic acid and pyrrolidone on the cerebral circulation].
    Lun'shina EV; Gan'shina TS; Mirzoian RS
    Eksp Klin Farmakol; 2002; 65(3):3-5. PubMed ID: 12227092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of pyrrolidone pharmacokinetics in rats].
    Sariev AK; Lun'shina EV; Zherdev VP
    Eksp Klin Farmakol; 2003; 66(6):50-2. PubMed ID: 14743713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroprotective properties of pyroglutamic acid in combination with pyrrolidone].
    Lun'shina EV; Gan'shina TS; Makarova LM; Pogorelyĭ VE; Mirzoian RS
    Eksp Klin Farmakol; 2003; 66(1):20-2. PubMed ID: 12683075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pyrrolidone-pyroglutamic acid composition on blood flow in rat middle cerebral artery.
    Semkina GA; Matsievskii DD; Mirzoyan NR
    Bull Exp Biol Med; 2006 Jan; 141(1):51-2. PubMed ID: 16929963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of an antiischemic drug combination and nimodipine on cerebral blood supply in a hemorrhagic stroke model in rats].
    Mirzoian NR; Gan'shina TS; Kurdiumov IN; Bero RS
    Eksp Klin Farmakol; 2008; 71(2):17-20. PubMed ID: 18488901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of pyrrolidone-2 on the cerebral circulation].
    Mirzoian SA; Ordian MB; Balasanian MG
    Biull Eksp Biol Med; 1987 Jan; 103(1):64-5. PubMed ID: 3801653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pyridoxine-pyrrolidone-carboxylate on hepatic adenosine triphosphate levels in rats.
    Baldacci M; Catalani R; Bartoli C; Mura U
    Boll Soc Ital Biol Sper; 1982 Dec; 58(24):1643-9. PubMed ID: 7168788
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental study of some pharmacodynamic properties of magnesium 2-pyrrolidone-5-carboxylate].
    Binet P; Miocque M; Pechery C; Roux M; Rinjard P
    Therapie; 1976; 31(4):471-81. PubMed ID: 137552
    [No Abstract]   [Full Text] [Related]  

  • 10. [A comparative study of the permeability across the hemato-encephalic barrier and of the effect on cerebral blood flow of the new neurotropic agent calcium ketohomopantothenate and of pantogam].
    Nasybullina NM; Gunar VI; Zherdev VP; Sariev AK; Kozlova GS; Mirzoian RS; Gan'shina TS; Karaev AL
    Eksp Klin Farmakol; 1997; 60(2):58-61. PubMed ID: 9206573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of action of piracetam on cerebral circulation].
    Akopian VP; Balian LS
    Farmakol Toksikol; 1987; 50(1):38-41. PubMed ID: 3556550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pyridoxine-pyrrolidon-carboxylate on hepatic and cerebral ATP levels in ethanol treated rats.
    Felicioli R; Saracchi I; Flagiello AM; Bartoli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):277-80. PubMed ID: 7192694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The central vascular and metabolic effects of pyroglutamic acid].
    Mirzoian SA; Zalinian MG; Balasanian MG; Topchian AV
    Eksp Klin Farmakol; 1994; 57(1):22-4. PubMed ID: 8142856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on insulin-like substances in Korean red ginseng.
    Takaku T; Kameda K; Matsuura Y; Sekiya K; Okuda H
    Planta Med; 1990 Feb; 56(1):27-30. PubMed ID: 2192378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pyroglutamic acid on corticostriatal glutamatergic transmission.
    Dusticier N; Kerkerian L; Errami M; Nieoullon A
    Neuropharmacology; 1985 Sep; 24(9):903-8. PubMed ID: 2997655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatography with fluorimetric detection in biological tissues of the 4-bromomethyl-7-methoxycoumarin ester derivative of 5-pyrrolidone-2-carboxylic acid.
    Bousquet E; Romeo G; Giannola LI
    J Chromatogr; 1985 Nov; 344():325-31. PubMed ID: 4086554
    [No Abstract]   [Full Text] [Related]  

  • 17. Pyrrolidone carboxylic acid in acute and chronic alcoholism. Preclinical and clinical studies.
    Pellegrini-Giampietro DE; Moroni F; Pistelli A; Palmerani B; Zorn AM; Peruzzi S; Caramelli L; Botti P; Valenza T; Antonini M
    Recenti Prog Med; 1989 Mar; 80(3):160-4. PubMed ID: 2740606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical method for identification of N-blocked group in pyroglutamic acid peptides.
    Gupta S; Sharma K; Narang CK; Mathur NK
    Indian J Biochem Biophys; 1984 Apr; 21(2):133-4. PubMed ID: 6490073
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of penetration-enhancing ability of laurocapram, N-methyl-2-pyrrolidone and dodecyl-L-pyroglutamate.
    Príborský J; Takayama K; Nagai T; Waitzová D; Elis J; Makino Y; Suzuki Y
    Pharm Weekbl Sci; 1988 Oct; 10(5):189-92. PubMed ID: 3060835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of esafosfina on cerebral circulation in intact and ischemized rat brain].
    Gan'shina TS; Aleksandrin VV; Mirzoian RS
    Eksp Klin Farmakol; 2004; 67(4):19-20. PubMed ID: 15500039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.